Literature DB >> 15380797

Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998.

Ali Shamseddine1, Abla-Mehio Sibai, Nageeb Gehchan, Boushra Rahal, Nagi El-Saghir, Marwan Ghosn, Georges Aftimos, Nabil Chamsuddine, Muhieddine Seoud.   

Abstract

PURPOSE: Cancer incidence rates in Lebanon have been lacking for over three decades. National data based on a total of 4388 cases diagnosed during the year 1998 were reviewed and analyzed.
METHODS: Crude and age-standardized rates (ASRs) per 100,000 population were calculated and results were contrasted with estimates from developed and selected developing countries in the region.
RESULTS: Among males, bladder (18.5%), prostate (14.2%), and lung cancer (14.1%) were the most frequently reported malignancies. Among females, breast cancer alone accounted for over a third of all cancers, followed by colon cancer (5.8%), and cancer of the corpus uteri (4.8%). Sex-differentials in incidence rates were highest for tobacco-related cancers (lung, larynx, and bladder). Compared with current estimates worldwide, ASRs for bladder cancer in Lebanon showed strikingly high rates. Whereas ASRs for breast and prostate cancer remained lower than those observed in developed countries, they were greater than those estimated from neighboring countries with a similar epidemiological transition as Lebanon.
CONCLUSIONS: Findings of the comparative assessments most likely reflect differentials in prevalence of risk factors and lifestyle variables (e.g., lung and breast cancers) and can be partly explained by improvement in cancer detection rate in recent years (for prostate cancer). The implications of the results in light of primary prevention activities, screening practices, and research initiatives in Lebanon are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15380797     DOI: 10.1016/j.annepidem.2003.12.002

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  29 in total

1.  Management of a patient diagnosed with pancreatic cancer and myelodysplastic syndrome.

Authors:  Elizabeth Won; Kenneth H Yu; Ali Shamseddine; Leonard Saltz; Deborah Mukherjee; Ali Haydar; Ashwaq El-Olayan; Sally Temraz; Mohamed Naghy; Dorothy Makanjoula; Eileen M O'Reilly; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2013-03

2.  A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses.

Authors:  Zaher K Otrock; Jad Saab; Georges Aftimos; Fady Nasr; Fadi S Farhat; Saad Khairallah; Gérard Abadjian; Marwan Ghosn; Hassan Sidani; Ahmad Ibrahim; Ayman Tawil; Claude Ghorra; Zarouhie Meguerian; Walid Mokaddem; Walid Dayeh; Ziad Salem; Georges Chahine; Nizar Bitar; Anas Mugharbel; Joseph Makdessi; Christina Khater; Mirna El Hajj; Dany Abi Gerges; Charles Sfeir; Joseph Kattan; Khaled Ibrahim; Michel Saade; Hussein Sadek; Rami A Mahfouz; Mohamed A Kharfan-Dabaja; Ghazi Zaatari; Ali Bazarbachi
Journal:  Pathol Oncol Res       Date:  2013-05-08       Impact factor: 3.201

3.  Cancer risk in different generations of Middle Eastern immigrants to California, 1988-2013.

Authors:  Clara Ziadeh; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Int J Cancer       Date:  2017-08-29       Impact factor: 7.396

4.  Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival.

Authors:  Cesar Yaghi; Ala-I Sharara; Paul Rassam; Rami Moucari; Khalil Honein; Joseph BouJaoude; Rita Slim; Roger Noun; Heitham Abdul-Baki; Mohamad Khalifeh; Sami Ramia; Raymond Sayegh
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

5.  CYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese population.

Authors:  Hussein A Basma; Loulou H Kobeissi; Michel E Jabbour; Mohamad A Moussa; Hassan R Dhaini
Journal:  Int J Mol Epidemiol Genet       Date:  2013-11-28

6.  Venous thromboembolism in cancer patients referred to the American University of Beirut-Medical Center secondary to deep vein thrombosis; occurrence and risk factors.

Authors:  Wissam H Sleiman Zade Asfahani; Ali T Taher; Denize Al Rahawi; Ismail Khalil
Journal:  J Thromb Thrombolysis       Date:  2005-12       Impact factor: 2.300

7.  BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.

Authors:  Nagi S El Saghir; Nathalie K Zgheib; Hussein A Assi; Katia E Khoury; Yannick Bidet; Sara M Jaber; Raghid N Charara; Rania A Farhat; Firas Y Kreidieh; Stephanie Decousus; Pierre Romero; Georges M Nemer; Ziad Salem; Ali Shamseddine; Arafat Tfayli; Jaber Abbas; Faek Jamali; Muhieddine Seoud; Deborah K Armstrong; Yves-Jean Bignon; Nancy Uhrhammer
Journal:  Oncologist       Date:  2015-03-16

8.  The tobacco industry's thwarting of marketing restrictions and health warnings in Lebanon.

Authors:  R Nakkash; K Lee
Journal:  Tob Control       Date:  2009-08       Impact factor: 7.552

9.  Adjuvant chemo-radiation for gastric adenocarcinoma: an institutional experience.

Authors:  Philippe G Aftimos; Elie A Nasr; Dolly I Nasr; Roger J Noun; Fady L Nasr; Marwan G Ghosn; Joelle A El Helou; Georges Y Chahine
Journal:  Radiat Oncol       Date:  2010-06-04       Impact factor: 3.481

10.  Deep targeted sequencing analysis of hot spot mutations in non-small cell lung cancer patients from the Middle Eastern population.

Authors:  Pierre Khoueiry; Ghina Fakhri; Reem Akel; Majd El Assaad; Rami Mahfouz; Fadlo Khuri; Hassan Chami; Jason Petersen; Sarah Viet; Gareth Davies; Humam Kadara; Arafat Tfayli
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.